PMC:7306567 / 17721-18057 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"201","span":{"begin":155,"end":167},"obj":"Chemical"},{"id":"202","span":{"begin":252,"end":266},"obj":"Chemical"},{"id":"205","span":{"begin":88,"end":101},"obj":"Disease"}],"attributes":[{"id":"A201","pred":"tao:has_database_id","subj":"201","obj":"MESH:D065819"},{"id":"A202","pred":"tao:has_database_id","subj":"202","obj":"MESH:D005436"},{"id":"A205","pred":"tao:has_database_id","subj":"205","obj":"MESH:D060085"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"A specific drug–drug interaction is relevant for patients with IAPA given the fact that co-infections with S. aureus are frequently observed; undetectable voriconazole levels have been observed in 11 of 20 patients, who were concomitantly treated with flucloxacillin [53], but the mechanisms of interaction are not yet fully understood."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T82","span":{"begin":91,"end":101},"obj":"Disease"}],"attributes":[{"id":"A82","pred":"mondo_id","subj":"T82","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"A specific drug–drug interaction is relevant for patients with IAPA given the fact that co-infections with S. aureus are frequently observed; undetectable voriconazole levels have been observed in 11 of 20 patients, who were concomitantly treated with flucloxacillin [53], but the mechanisms of interaction are not yet fully understood."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T115","span":{"begin":0,"end":1},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T116","span":{"begin":197,"end":199},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"}],"text":"A specific drug–drug interaction is relevant for patients with IAPA given the fact that co-infections with S. aureus are frequently observed; undetectable voriconazole levels have been observed in 11 of 20 patients, who were concomitantly treated with flucloxacillin [53], but the mechanisms of interaction are not yet fully understood."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T122","span":{"begin":11,"end":15},"obj":"Chemical"},{"id":"T123","span":{"begin":16,"end":20},"obj":"Chemical"},{"id":"T124","span":{"begin":155,"end":167},"obj":"Chemical"},{"id":"T125","span":{"begin":252,"end":266},"obj":"Chemical"}],"attributes":[{"id":"A122","pred":"chebi_id","subj":"T122","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A123","pred":"chebi_id","subj":"T123","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A124","pred":"chebi_id","subj":"T124","obj":"http://purl.obolibrary.org/obo/CHEBI_10023"},{"id":"A125","pred":"chebi_id","subj":"T125","obj":"http://purl.obolibrary.org/obo/CHEBI_5098"}],"text":"A specific drug–drug interaction is relevant for patients with IAPA given the fact that co-infections with S. aureus are frequently observed; undetectable voriconazole levels have been observed in 11 of 20 patients, who were concomitantly treated with flucloxacillin [53], but the mechanisms of interaction are not yet fully understood."}

{"project":"LitCovid-sentences","denotations":[{"id":"T118","span":{"begin":0,"end":336},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"A specific drug–drug interaction is relevant for patients with IAPA given the fact that co-infections with S. aureus are frequently observed; undetectable voriconazole levels have been observed in 11 of 20 patients, who were concomitantly treated with flucloxacillin [53], but the mechanisms of interaction are not yet fully understood."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T141","span":{"begin":11,"end":15},"obj":"CHEBI:23888;CHEBI:23888"},{"id":"T142","span":{"begin":16,"end":20},"obj":"CHEBI:23888;CHEBI:23888"},{"id":"T143","span":{"begin":107,"end":108},"obj":"NCBITaxon:4932"},{"id":"T144","span":{"begin":108,"end":109},"obj":"NCBITaxon:562"},{"id":"T145","span":{"begin":155,"end":167},"obj":"CHEBI:10023;CHEBI:10023"},{"id":"T146","span":{"begin":252,"end":266},"obj":"CHEBI:5098;CHEBI:5098"},{"id":"T5704","span":{"begin":11,"end":15},"obj":"CHEBI:23888;CHEBI:23888"},{"id":"T23687","span":{"begin":16,"end":20},"obj":"CHEBI:23888;CHEBI:23888"},{"id":"T76380","span":{"begin":107,"end":108},"obj":"NCBITaxon:4932"},{"id":"T2256","span":{"begin":108,"end":109},"obj":"NCBITaxon:562"},{"id":"T62223","span":{"begin":155,"end":167},"obj":"CHEBI:10023;CHEBI:10023"},{"id":"T32565","span":{"begin":252,"end":266},"obj":"CHEBI:5098;CHEBI:5098"}],"text":"A specific drug–drug interaction is relevant for patients with IAPA given the fact that co-infections with S. aureus are frequently observed; undetectable voriconazole levels have been observed in 11 of 20 patients, who were concomitantly treated with flucloxacillin [53], but the mechanisms of interaction are not yet fully understood."}

{"project":"2_test","denotations":[{"id":"32572532-28717040-47963442","span":{"begin":268,"end":270},"obj":"28717040"},{"id":"T52416","span":{"begin":268,"end":270},"obj":"28717040"}],"text":"A specific drug–drug interaction is relevant for patients with IAPA given the fact that co-infections with S. aureus are frequently observed; undetectable voriconazole levels have been observed in 11 of 20 patients, who were concomitantly treated with flucloxacillin [53], but the mechanisms of interaction are not yet fully understood."}